BR100 Increased By (0.43%)
BR30 Increased By (0.76%)
KSE100 Increased By (0.46%)
KSE30 Increased By (0.42%)
AGHA 6.50 Increased By ▲ 0.05 (0.78%)
BECO 4.15 Decreased By ▼ -0.01 (-0.24%)
BML 58.55 Increased By ▲ 1.24 (2.16%)
BOP 28.24 Increased By ▲ 0.09 (0.32%)
CNERGY 12.51 Increased By ▲ 0.10 (0.81%)
CSIL 5.38 Increased By ▲ 0.02 (0.37%)
FCCL 51.37 Decreased By ▼ -0.29 (-0.56%)
FFL 13.92 Increased By ▲ 0.02 (0.14%)
FNEL 1.09 Increased By ▲ 0.01 (0.93%)
KEL 5.72 No Change ▼ 0.00 (0%)
KOSM 5.30 Decreased By ▼ -0.03 (-0.56%)
LOTCHEM 24.16 Decreased By ▼ -0.09 (-0.37%)
MLCF 89.70 Increased By ▲ 0.06 (0.07%)
NBP 157.00 Increased By ▲ 0.43 (0.27%)
NCPL 51.72 Increased By ▲ 4.70 (10%)
NPL 57.16 Increased By ▲ 5.20 (10.01%)
OGDC 303.05 Increased By ▲ 3.04 (1.01%)
PACE 9.29 Increased By ▲ 0.03 (0.32%)
PAEL 33.05 Increased By ▲ 0.04 (0.12%)
PIBTL 13.10 Decreased By ▼ -0.09 (-0.68%)
PPL 216.50 Increased By ▲ 2.18 (1.02%)
PRL 99.55 Decreased By ▼ -1.89 (-1.86%)
PTC 52.10 Decreased By ▼ -0.14 (-0.27%)
SSGC 23.25 Increased By ▲ 0.10 (0.43%)
TBL 9.00 Decreased By ▼ -0.09 (-0.99%)
TELE 7.00 Increased By ▲ 0.02 (0.29%)
TPL 22.05 Increased By ▲ 0.01 (0.05%)
TPLP 11.50 Decreased By ▼ -0.19 (-1.63%)
TREET 23.20 Increased By ▲ 0.40 (1.75%)
TRG 56.76 Decreased By ▼ -0.37 (-0.65%)
World

Singapore approves COVID-19 vaccine for children ages 5 to 11

Published Updated
By

SINGAPORE: Singapore will start COVID-19 vaccinations for children aged 5 to 11 years before the end of this year, its health ministry said late on Friday.

The Southeast Asian city-state has already vaccinated 87% of its 5.5 million populations, and authorities were rushing to get children vaccinated amid concerns over rising number of paediatric COVID-19 cases.

AstraZeneca to supply COVID-19 antibody cocktail to Singapore

The dosage used for children will be one-third of that used in adults, similar to the United States.

Currently, only Pfizer-BioNTech "Comirnaty" vaccine has been approved for children's usage in Singapore, the health ministry added.

Singapore has also signed a new supply agreement with Pfizer-BioNTech for the COVID-19 vaccine, it said, without specifying how many vials will be supplied.

Comments

Comments are closed for this article.